193 related articles for article (PubMed ID: 24643839)
1. [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment].
Bellmann R
Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):162-6. PubMed ID: 24643839
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
Nosseir NS; Michels G; Pfister R; Adam R; Wiesen MH; Müller C
Dtsch Med Wochenschr; 2014 Sep; 139(38):1889-94. PubMed ID: 25203549
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial management of sepsis and septic shock.
Sharma S; Kumar A
Clin Chest Med; 2008 Dec; 29(4):677-87, ix. PubMed ID: 18954702
[TBL] [Abstract][Full Text] [Related]
7. Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock.
Huang Y; Xu K; Zhan Y; Zha X; Liu S; Xie J; Liu L; Li Q; Shao H; Yang Y
Adv Ther; 2020 May; 37(5):2246-2255. PubMed ID: 32277344
[TBL] [Abstract][Full Text] [Related]
8. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study.
Zhao HY; Gu J; Lyu J; Liu D; Wang YT; Liu F; Zhu FX; An YZ
Chin Med J (Engl); 2017 May; 130(10):1139-1145. PubMed ID: 28485312
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality.
Díaz-Martín A; Martínez-González ML; Ferrer R; Ortiz-Leyba C; Piacentini E; Lopez-Pueyo MJ; Martín-Loeches I; Levy MM; Artigas A; Garnacho-Montero J;
Crit Care; 2012 Nov; 16(6):R223. PubMed ID: 23158399
[TBL] [Abstract][Full Text] [Related]
11. [Tissue penetration of antibiotics. Does the treatment reach the target site?].
Lagler H; Zeitlinger M
Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):175-81. PubMed ID: 24691884
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock.
Vázquez M; Fagiolino P; Boronat A; Buroni M; Maldonado C
Int J Clin Pharmacol Ther; 2008 Mar; 46(3):140-5. PubMed ID: 18397685
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
De Paepe P; Belpaire FM; Buylaert WA
Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis.
Fujii M; Karumai T; Yamamoto R; Kobayashi E; Ogawa K; Tounai M; Lipman J; Hayashi Y
Expert Opin Drug Metab Toxicol; 2020 May; 16(5):415-430. PubMed ID: 32238005
[No Abstract] [Full Text] [Related]
15. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
Marsot A
J Pharm Pharm Sci; 2020; 23():470-485. PubMed ID: 33227230
[TBL] [Abstract][Full Text] [Related]
16. [Adequate anti-infective treatment : Importance of individual dosing and application].
Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic therapy in sepsis: No next time for a second chance!
Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
[TBL] [Abstract][Full Text] [Related]
18. A new paradigm for treating infections: "go hard and go home".
Lipman J; Boots R
Crit Care Resusc; 2009 Dec; 11(4):276-81. PubMed ID: 20001878
[TBL] [Abstract][Full Text] [Related]
19. [Pitfalls in determining resistance].
Rodloff AC
Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):182-6. PubMed ID: 24696279
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock.
Borsuk-De Moor A; Rypulak E; Potręć B; Piwowarczyk P; Borys M; Sysiak J; Onichimowski D; Raszewski G; Czuczwar M; Wiczling P
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
